Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Tuesday, January 31, 2017


PulmCrit (EMCrit)
PulmCrit - January 30, 2017 - By Josh Farkas
..."The Surviving Sepsis Campaign was founded on the basis of early goal-directed therapy. As this was disproven, the campaign stubbornly clung to it (for example, continuing to recommend CVP monitoring in 2014). The current guidelines have finally removed early goal-directed therapy, since to do otherwise would have rendered them irredeemably obsolete.
However, many vestiges of early goal-directed therapy remain in the current guidelines (e.g. serial lactate measurement). We must take a hard, objective look at such therapies to determine if they still stand up, now that early goal-directed therapy has collapsed...
  • Myth #6: Combination therapy is beneficial for gram-negative septic shock.
  • Myth #5: Norepinephrine is the best vasopressor for all septic patients.
  • Myth #4: If one vasopressor doesn’t work, additional drugs should be added in a sequential fashion.
  • Myth #3: Lactate is a measure of tissue perfusion. Normalization of lactate should be used as a resuscitation target.
  • Myth #2: All septic patients must receive 30 ml/kg fluid initially.
  • Myth #1: It’s helpful to mandate that specific sepsis therapies be given within a rigid time frame."